Skip to content

The Clinical Effect of Remimazolam Tosilate for Injection Combined with Sufentanil in patients with Cirrhosis Undergoing Painless Gastroscopy

The Clinical Effect of Remimazolam Tosilate for Injection Combined with Sufentanil in patients with Cirrhosis Undergoing Painless Gastroscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037722
Enrollment
Unknown
Registered
2020-09-03
Start date
2020-08-20
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless Gastroscopy

Interventions

experimental group 1:infusion of sufentanil 0.1-0.2ug/kg and remimazolam tosilate 5mg
experimental group 2:infusion of sufentanil 0.1-0.2ug/kg and remimazolam tosilate 4.5mg
control group:infusion of sufentanil 0.1-0.2ug/kg and propofol 1.5-2.0mg/kg

Sponsors

Beijing You'an Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cirrhosis caused by various causes; 2. ASA II, III; 3. Patients aged 18-65 years old; 4. Patients with child Pugh grade a liver function; 5. Patients who agree to receive sedation or anesthesia gastroscopy and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to routine gastroscopy; 2. Patients who refuse to accept sedation or anesthesia gastroscopy; 3. Patients allergic to sedatives and anesthetics; 4. Patients who can not accept the questionnaire due to various reasons.

Design outcomes

Primary

MeasureTime frame
Perioperative respiratory depression;

Secondary

MeasureTime frame
physical activity;Vital signs at each time point;Drug onset time;Time to rcovery of consciousness;Postoperative adverse reactions;Satisfaction of patients and operating physicians;

Countries

China

Contacts

Public ContactYinghao Cao

Beijing You'an Hospital Affiliated to Capital Medical University

cyhbj@sina.cn+86 13601091691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026